BackCelgene Overview

Celgene Other Liabilities

Track Celgene's other liabilities ($2.5B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$2.45B
↑ 0.12% YoYΔ $3.00M vs prior year quarter

Peer average

Loading

Celgene Other Liabilities History

Loading

Celgene vs. peers: Other Liabilities Comparison

Loading

Celgene Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Celgene (CELG) FAQ

As of the most recent data (September 2019), CELG shows a other liabilities of $2.5B. That compares with $2.5B in the prior-year period — up 0.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CELG's other liabilities is now $2.5B (was $2.5B) — a 0.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Celgene is outperforming or lagging.

Tracking CELG's other liabilities over time shows whether Celgene is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5B That compares with $2.5B in the prior-year period — up 0.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Celgene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $2.5B) with ownership activity and broader fundamentals.